Global Metabolomics Market 2014-2018

Global Metabolomics Market 2014-2018

Category : Healthcare
Published On : July  2014
Pages : 86



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

About Metabolomics
Metabolomics or Metabonomics is the scientific study of chemical processes involving metabolites. Metabolomics has become a new experimental technique that is being widely used in biology, medicine and the environmental sciences. Metabolites are small molecules that are present in blood, urine, and tissues. The pattern, or fingerprint, of metabolites in a biological sample is used to learn about the health of organisms. The unique patterns of metabolites are widely used to diagnose specific diseases. A metabolome is the terminology used in metabolomics to describe the comprehensive and quantitative analysis of all the metabolites of an organism.   Metabolomics is a relatively new field of omics research compared to other similar fields such as genomics, proteomics, and transcriptomics. 
TechNavio's analysts forecast the Global Metabolomics market will grow at a CAGR of 24.26 percent over the period 2013-2018.
Covered in this Report
The Global Metabolomics market can be divided into eight segments: Mass Spectroscopy, Nuclear Magnetic Resonance Spectroscopy, Gas Chromatography, High Performance Liquid Chromatography, Metabolomics-on-a-chip, Fourier-Transform Infrared Spectroscopy, Capillary Electrophoresis, and Electrochemical Array. These are the sets of methodologies and technologies that transform unstructured and structured data into meaningful and useful information processes.
TechNavio's report, the Global Metabolomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Metabolomics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
• APAC
Key Vendors
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corp.
• Human Metabolome Technologies Inc.
• Metabolon Inc.
Other Prominent Vendors
 
• Acadia Pharmaceuticals 
• Accelrys
• BG Medicine
• Biocrates Life Sciences
• Chenomx
• Life Technologies
• Metabolomic Technologies 
• Nanosyn
• PerkinElmer
• Waters
Key Market Driver
• Increase in Prevalence of Cancer and Diabetes
• For a full, detailed list, view our report
Key Market Challenge
• Quality Control Standards of Metabolic Profiling Data 
• For a full, detailed list, view our report
Key Market Trend
• Emergence of Standards to Analyze Metabolomics Data
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

 

 

 



01. Executive Summary

02. List of Abbreviations

03. Scope of the Report


03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape


06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation


09.1 Metabolomics Market in the Americas

09.1.1 Market Size and Forecast

09.2 Metabolomics Market in the EMEA

09.2.1 Market Size and Forecast

09.3 Metabolomics Market in the APAC

09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape


17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Agilent Technologies

18.1.1 Key Facts

18.1.2 Business Overview

18.1.3 Business Segmentation by Revenue 2013

18.1.4 Business Segmentation by Revenue 2012 and 2013

18.1.5 Sales by Geography

18.1.6 Business Strategy

18.1.7 Key Information

18.1.8 SWOT Analysis

18.1.9 Strengths

18.1.10 Weaknesses

18.1.11 Opportunities

18.1.12 Threats

18.2 Bio-Rad Laboratories

18.2.1 Key Facts

18.2.2 Business Overview

18.2.3 Business Segmentation by Revenue 2012

18.2.4 Business Segmentation by Revenue 2012 and 2011

18.2.5 Geographical Segmentation by Revenue 2012

18.2.6 Business Strategy

18.2.7 Recent Developments

18.2.8 SWOT Analysis

18.2.9 Strengths

18.2.10 Weakness

18.2.11 Opportunities

18.2.12 Threats

18.3 Bruker

18.3.1 Key Facts

18.3.2 Business Overview/ Description

18.3.3 Business Segmentation

18.3.4 Business Strategy

18.3.5 Revenue Segmentation by Business /Products

18.3.6 Sales by Geographical Segmentation

18.3.7 Key Information

18.3.8 SWOT Analysis

18.3.9 Strengths

18.3.10 Weaknesses

18.3.11 Opportunities

18.3.12 Threats

18.4 Human Metabolome Technologies

18.4.1 Key Facts

18.4.2 Business Overview/ Description

18.4.3 Business Segmentation

18.4.4 Business Strategy

18.4.5 Revenue Segmentation by Business

18.4.6 Sales by Geographical Segmentation

18.4.7 Key Information

18.4.8 SWOT Analysis

18.4.9 Strengths

18.4.10 Weaknesses

18.4.11 Opportunities

18.4.12 Threats

18.5 Metabolon Inc.

18.5.1 Key Facts

18.5.2 Business Overview/Description

18.5.3 Business Segmentation

18.5.4 Business Strategy

18.5.5 Key Information

18.5.6 SWOT Analysis

18.5.7 02.2.1  Strengths

18.5.8 02.2.2  Weaknesses

18.5.9 02.2.3  Opportunities

18.5.10 02.2.4   Threats

19. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Metabolomics Market 2013-2018 (US$ million)

Exhibit 3: Global Metabolomics Market Segmentation by Technology

Exhibit 4: Global Metabolomics Market Segmentation by Application

Exhibit 5: Global Metabolomics Market by Geographical Segmentation 2013

Exhibit 6: Global Metabolomics market by Geographical Segmentation in 2018

Exhibit 7: Metabolomics Market  in the Americas 2013-2018 (US$ million)

Exhibit 8: Metabolomics market  in the EMEA region 2013-2018 (US$ million)

Exhibit 9: Metabolomics Market  in the APAC region 2013-2018 (US$ million)

Exhibit 10: Agilent Technologies Inc.: Business Segmentation by Revenue 2013

Exhibit 11: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)

Exhibit 12: Agilent Technologies Inc.: Sales by Geography 2013

Exhibit 13: Bio-Rad Laboratories: Business Segmentation by Revenue 2012

Exhibit 14: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)

Exhibit 15: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012

Exhibit 16: Business segments for Human Metabolome Technologies

Exhibit 17: Revenue Segmentation of Global Metabolomics Market 2014-2018 for 2013

Exhibit 18: Revenue Segmentation of Global Metabolomics Market 2014-2018 by Geography for 2013

Exhibit 19:   Metabolon Inc. Business Segmentation


 



Enquiry Before Buy